Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Vincenzovegaon Apr 16, 2022 11:03pm
202 Views
Post# 34608064

RE:My OPINION only - Why AcuVid will get FDA EUA

RE:My OPINION only - Why AcuVid will get FDA EUAI was wrong, they say the average successful approval takes 8 days, so from March 29, 2022 til now, well I can say I'm well off, I though we'd be approved by now. Now this breathalyzer was submitted for EUA on August 18, 2021. Now I question myself is it possible AcuVid being approved by the end of this month? Can we compare? Is it like comparing apples with oranges?
With all the new possible direction we can go, along with AcuVid and the other devices we already have, Therma has a great potential 
future.
“The company has begun investigating another saliva-based testing technology incorporating a robust platform for detecting other respiratory infectious diseases affecting the lungs and a novel saliva-based platform for Neuro-Vascular disorders, (e.g. PTSD, head trauma/concussion)," 

Thanks Watchman21 and Smokey1958 for your posting...
<< Previous
Bullboard Posts
Next >>